Xtl Biopharmaceuticals Ltd Stock Price Prediction

Intrinsic Valuation Low Real High 0.08 1.69 9.52 Details

XTL Biopharmaceutica After-Hype Price Prediction Density Analysis

XTL Biopharmaceutica Estimiated After-Hype Price Volatility

XTL Biopharmaceutica Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.08	7.83	0.01	0.01	6 Events / Month	3 Events / Month	In about 6 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
2.10	2.11	0.48	9,788   Notes

XTL Biopharmaceutica Hype Timeline

XTL Biopharmaceuticals is at this time traded for 2.10. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.01. XTL is expected to increase in value after the next headline, with the price projected to jump to 2.11 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.48%, whereas the daily expected return is at this time at 0.08%. The volatility of related hype on XTL Biopharmaceutica is about 7528.85%, with the expected price after the next announcement by competition of 2.09. Net Loss for the year was (1.78 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out XTL Biopharmaceutica Basic Forecasting Models to cross-verify your projections.

XTL Biopharmaceutica Related Hype Analysis

XTL Biopharmaceutica Additional Predictive Modules

Most predictive techniques to examine XTL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for XTL using various technical indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of XTL Biopharmaceutica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as XTL Biopharmaceuticals Ltd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of XTL Biopharmaceutica based on analysis of XTL Biopharmaceutica hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for XTL Biopharmaceutica depends on current market conditions and XTL Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that XTL Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about XTL Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

XTL Biopharmaceutica's future price predictability will typically decrease when XTL Biopharmaceutica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of XTL Biopharmaceuticals Ltd often depends not only on the future outlook of the potential XTL Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XTL Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.